Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
8
×
biotech
life sciences
national blog main
boston blog main
boston top stories
san francisco blog main
clinical trials
new york blog main
new york top stories
san francisco top stories
startups
investing
national top stories
boston
fda
biotech ipos
cancer immunotherapy
gene editing
ipo
medical device
national
rare diseases
renaissance capital
san diego blog main
san diego top stories
san francisco
vc
10x genomics
480 biomedical
abbvie
acetylon pharmaceuticals
acute myeloid leukemia
allergan
alx oncology
alzheimer's disease
ambys medicines
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
What
biotech
8
×
new
medicines
research
companies
ipo
markets
science
abbvie
company
days
developing
formed
life
public
raised
startup
street
therapeutics
today
wall
way
week
welcomed
abbott
agreement
ahead
aiming
aims
alliance
ambien
ambys
american
announced
annual
approach
arrival
asco
attendees
attention
Language
unset
Current search:
deals
×
biotech
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center